[Hypertension in haemodialysis and peritoneal dialysis patients].
Hypertension occurs in many reports in 80-100% ESRD patients and is the most important risk factor of cardiovascular morbidity and mortality. Successful therapy of hypertension depends on many factors including specific, pathophysiological mechanisms, ability of optimal renal replacement therapy and pharmacotherapy in the circumstances of different drugs pharmacokinetics. The review is aimed on recent reports concerning the role of optimal dialysis especially dose, duration of the procedure and some pharmacological aspects of blood pressure control in ESRD patients.
Klinger
Marian
M
Katedra i Klinika Nefrologii i Medycyny Transplantacyjnej Akademii Medycznej we Wrocławiu. klinef@am.centrum.pl
Porazko
Tomasz
T
Banasik
Mirosław
M
D006801:Humans; D006973:Hypertension / Q000453:epidemiology*; D010530:Peritoneal Dialysis / Q000706:statistics & numerical data*; D006435:Renal Dialysis / Q000706:statistics & numerical data*